Glaukos Corporation
GKOS
Ранг среди акций
#2114
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Цена акции
$164.43
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$9.70B
Изменение (1 день)
-0.95%
Изменение (1 год)
88.63%
Страна
US
Торговля Glaukos Corporation (GKOS)
Категория
Healthcare
EPS для Glaukos Corporation (GKOS)
EPS по состоянию на June 2026 TTM: $-3.25
Согласно последним финансовым отчетам и цене акций Glaukos Corporation, текущий EPS компании (TTM) составляет $-3.25. В конце 2023 EPS компании составлял $-2.78, больше, чем показателю 2022 года, равному $-2.09.
История EPS компании Glaukos Corporation с 2012 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $-3.25 | 17.33% |
| 2024 | $-2.77 | -0.36% |
| 2023 | $-2.78 | 33.01% |
| 2022 | $-2.09 | 95.33% |
| 2021 | $-1.07 | -60.37% |
| 2020 | $-2.70 | -758.54% |
| 2019 | $0.41 | -210.81% |
| 2018 | $-0.37 | 13,603.70% |
| 2017 | 0.00 | -101.93% |
| 2016 | $0.14 | -106.57% |
| 2015 | $-2.13 | 334.69% |
| 2014 | $-0.49 | -3.92% |
| 2013 | $-0.51 | -94.76% |
| 2012 | $-9.73 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $3.11 | -195.69% |
US
|
|
| $3.59 | -210.46% |
IE
|
|
| $9.73 | -399.38% |
US
|
|
| $2.48 | -176.31% |
US
|
|
| - | - |
DE
|
